Rationale for a nanomedicine approach to thrombolytic therapy.
Lanza GM, Marsh JN, Hu G, Scott MJ, Schmieder AH, Caruthers SD, Pan D, Wickline SA.
Lanza GM, et al. Among authors: marsh jn.
Stroke. 2010 Oct;41(10 Suppl):S42-4. doi: 10.1161/STROKEAHA.110.598656.
Stroke. 2010.
PMID: 20876503
Free PMC article.
Review.
No abstract available.